Medical-Nutrition-Therapy for Obese Patients with Type 2 Diabetes Mellitus Undergoing Metabolic Surgery.
- Author:
Hye Jin KIM
1
;
Sin A NAMGUNG
;
Jeong Im HONG
;
Hee Jung MOK
Author Information
1. Department of Nutrition, Yeouido St. Mary's Hospital, Catholic University, Seoul 150-713, Korea. nksa20@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
laparoscopic Roux-en Y gastric bypass (LRYGB);
metabolic surgery;
medical nutrition therapy;
diabesity;
T2DM
- MeSH:
Blood Glucose;
Carbohydrates;
Diabetes Mellitus, Type 2;
Diet;
Fasting;
Gastric Bypass;
Humans;
Nutrition Therapy;
Organothiophosphorus Compounds;
Retrospective Studies;
Vomiting;
Weight Loss
- From:Journal of the Korean Dietetic Association
2011;17(2):206-215
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Currently, metabolic surgery (Laparoscopic Roux-en-Y gastric bypass, LRYGB) has an important role and should be recommended as an intervention in the management of obese patients with type 2 diabetes mellitus (T2DM). A successful outcome of surgery requires medical nutrition therapy. Therefore, we performed a retrospective study on 25 patients with T2DM who underwent LRYGB at Yeouido St. Mary's Hospital from October 2008 to May 2010. The patients were followed up for an average of 6 months after surgery (range: 2~19 months). Diabetes was resolved in 80% of the patients. Percentage of excess weight loss was (%EWL) was 56.2%. After surgery, fasting blood sugar (FBS) and HbA1c were significantly reduced (123 mg/dl, A1c 6.7%, P<0.001) and triglyceride was also significantly reduced to 107.6 mg/dl (P<0.05). As diets of the patients progressed from liquid to soft to regular diet, energy, carbohydrates, and fat intakes increased significantly (P<0.001). But protein intake did not change significantly. Nutrient intake of the patients after the surgery was significantly lower than the recommended diet for the non-surgery group. Patients experienced side-effects related to the diets after surgery, including hair-loss (76%), smelly gas (52%), vomiting (48%), etc. A significantly positive correlation was observed between vomiting and FBS (P<0.001). There was a significant relationship between side effects and the amount of nutrient intakes. Therefore, guide patients to a diet progression with treatment to minimize side effects, especially vomiting. And monitor their dietary life to be healthy and not to regain weight until remission of T2DM.
